NR3C1 and neoplasm: For example, we have shown that GR can inhibit tumor cell proliferation in ER+ IDC cell lines by decreasing estrogen-mediated proliferative gene expression and G1/S cell cycle progression, including cyclin D1 (CCND1) gene expression [16].